Comparative Evaluation of the VITEK 2, Disk Diffusion, Etest, Broth Microdilution, and Agar Dilution Susceptibility Testing Methods for Colistin in Clinical Isolates, Including Heteroresistant Enterobacter cloacae and Acinetobacter baumannii Strains
Open accessAbstract
Increasing antibiotic resistance in gram-negative bacteria has recently renewed interest in colistin as a therapeutic option. The increasing use of colistin necessitates the availability of rapid and reliable methods for colistin susceptibility testing. We compared seven methods of colistin susceptibility testing (disk diffusion, agar dilution on Mueller-Hinton [MH] and Isosensitest agar, Etest on MH and Isosensitest agar, broth microdilution, and VITEK 2) on 102 clinical isolates collected from patient materials during a selective digestive decontamination or selective oral decontamination trial in an intensive-care unit. Disk diffusion is an unreliable method to measure susceptibility to colistin. High error rates and low levels of reproducibility were observed in the disk diffusion test. The colistin Etest, agar dilution, and the VITEK 2 showed a high level of agreement with the broth microdilution reference method. Heteroresistance for colistin was observed in six Enterobacter cloacae isolates and in one Acinetobacter baumannii isolate. This is the first report of heteroresistance to colistin in E. cloacae isolates. Resistance to colistin in these isolates seemed to be induced upon exposure to colistin rather than being caused by stable mutations. Heteroresistant isolates could be detected in the broth microdilution, agar dilution, Etest, or disk diffusion test. The VITEK 2 displayed low sensitivity in the detection of heteroresistant subpopulations of E. cloacae . The VITEK 2 colistin susceptibility test can therefore be considered to be a reliable tool to determine susceptibility to colistin in isolates of genera that are known not to exhibit resistant subpopulations. In isolates of genera known to (occasionally) exhibit heteroresistance, an alternative susceptibility testing method capable of detecting heteroresistance should be used.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
E-test results significantly correlate with MIC values obtained through broth or agar dilution methods.
“studies have shown a significant correlation between E-test results and MIC values obtained through broth or agar dilution methods [69, 70].”
From Methods for screening and evaluation of antimicrobial activity: A review of protocols, advantages, and limitations (2024) · cites this paper as [69]
The Results (page not supplied) report relatively high agreement between Etest and broth microdilution for colistin susceptibility testing, with exceptions among heteroresistant isolates. They do not report a direct Etest–agar dilution comparison or a statistical test establishing that the correlation was significant. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,745 · see citing works
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K. P., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,389 · see citing works
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759 · see citing works
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. P. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 573 · see citing works
Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria
Evans, M. E., Feola, D. J., & Rapp, R. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18426 · Cited by 550 · see citing works
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 549 · see citing works
Gales, A. C., Reis, A. O., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.183-190.2001 · Cited by 381 · see citing works
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests
MacGowan, A. P., & Wise, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.17 · Cited by 187 · see citing works
Arroyo, L. A. R., García-Curiel, A., Pachón-Ibáñez, M. E., Llanos, A. C., Ruiz, M. T., Pachón, J., & Aznar, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.903-905.2005 · Cited by 130 · see citing works
Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin
Tan, T. Y., & Ng, S. Y. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01708.x · Cited by 126 · see citing works
Members of the SFM Antibiogram Committee (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00021-9 · Cited by 122 · see citing works
Comparison of three standardized disc susceptibility testing methods for colistin
Tan, T. Y. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl330 · Cited by 100 · see citing works
Nicodemo, A. C. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh128 · Cited by 99 · see citing works
The development of the BSAC standardized method of disc diffusion testing
Andrews, J. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.29 · Cited by 83 · see citing works
The in-vitro activity of colistin in gram-negative bacteria.
Tan, T. Y., & Ng, S. Y. (2006) · PubMed · Cited by 51 · see citing works
Jones, R. N., Anderegg, T. R., & Swenson, J. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.925-927.2005 · Cited by 42 · see citing works
Roychoudhury, S. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.29 · Cited by 40 · see citing works
Goldstein, F. W., Ly, A., & Kitzis, M. D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm046 · Cited by 37 · see citing works
Pollock, H. M., Minshew, B. H., Kenny, M. A., & Schoenknecht, F. D. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.3.360 · Cited by 35 · see citing works
Background for Different Use of Antibiotics in Different Countries
Llor, C., & Bjerrum, L. (2004) · Clinical Infectious Diseases · doi:10.1086/427035 · Cited by 18 · see citing works
Andrews, J. M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf181 · Cited by 12 · see citing works
Landrygan, J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.2.391 · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [18]SFM Antibiogram Committee. 2003. Comite de l'Antibiogramme de la Société Française de Microbiologie report 2003. Int. J. Antimicrob Agents. 21:364-391. [DOI] [PubMed] [Google Scholar]
Cited by
Sorted by citations
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,331 · see citing works
Poirel, L., Jayol, A., & Nordmann, P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-16 · Cited by 1,476 · see citing works
Landman, D., Georgescu, C., Martin, D. A., & Quale, J. M. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-08 · Cited by 573 · see citing works
Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic Resistance
Mezzatesta, M. L., Gona, F., & Stefani, S. (2012) · Future Microbiology · doi:10.2217/fmb.12.61 · Cited by 571 · see citing works
Mechanisms and clinical relevance of bacterial heteroresistance
Andersson, D. I., Nicoloff, H., & Hjort, K. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0218-1 · Cited by 513 · see citing works
Antimicrobial heteroresistance: An emerging field in need of clarity
El-Halfawy, O. M., & Valvano, M. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-14 · Cited by 489 · see citing works
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Nang, S. C., Azad, M. A. K., Velkov, T., Zhou, Q. (., & Li, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000020 · Cited by 428 · see citing works
Nicoloff, H., Hjort, K., Levin, B. R., & Andersson, D. I. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0342-0 · Cited by 406 · see citing works
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379 · see citing works
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Gordon, N. C., & Wareham, D. W. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.024 · Cited by 378 · see citing works
Hossain, T. J. (2024) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2024.00035 · Cited by 392 · see citing works
Hindler, J. A., & Humphries, R. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03385-12 · Cited by 240 · see citing works
Catry, B., Cavaleri, M., Baptiste, K. E., Grave, K., Grein, K., Holm, A., Jukes, H., Liébana, E., Navas, A. L., Mackay, D., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.06.005 · Cited by 237 · see citing works
Chew, K. L., La, M.-V., Lin, R. T. P., & Teo, J. W. P. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00268-17 · Cited by 211 · see citing works
Gordon, N. C., P'ng, K. M. Y., & Wareham, D. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00922-10 · Cited by 192 · see citing works
Clinical Pharmacokinetics and Pharmacodynamics of Colistin
Grégoire, N., Aranzana‐Climent, V., Magréault, S., Marchand, S., & Couet, W. R. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0561-1 · Cited by 192 · see citing works
Halaby, T., al Naiemi, N., Kluytmans, J. A. J. W., van der Palen, J. A. M., & Vandenbroucke‐Grauls, C. M. J. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02634-12 · Cited by 182 · see citing works
Self-citationPelletier, M. R., Casella, L. G., Jones, J. W., Adams, M. D., Zurawski, D. V., Hazlett, K. R. O., Doi, Y., & Ernst, R. K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00865-13 · Cited by 175 · see citing works
Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside
Maria-Neto, S., de Almeida, K. C., Macedo, M. L. R., & Franco, O. L. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.02.017 · Cited by 173 · see citing works
Colistin susceptibility testing by Etest and disk diffusion methods
Galani, I., Kontopidou, F. V., Souli, M., Rekatsina, P. D., Koratzanis, E., Deliolanis, J., & Giamarellou, H. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.01.011 · Cited by 169 · see citing works
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011) · Future Microbiology · doi:10.2217/fmb.11.49 · Cited by 167 · see citing works
Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
Bergen, P. J., Landersdorfer, C. B., Zhang, J., Zhao, M., Lee, H. J., Nation, R. L., & Li, J. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.07.010 · Cited by 162 · see citing works
Dafopoulou, K., Zarkotou, O., Dimitroulia, E., Hadjichristodoulou, C. S., Gennimata, V., Pournaras, S., & Tsakris, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00868-15 · Cited by 154 · see citing works
Al‐Tawfiq, J. A., Laxminarayan, R., & Mendelson, M. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.11.415 · Cited by 142 · see citing works
A multiplexed microfluidic platform for rapid antibiotic susceptibility testing
Mohan, R., Mukherjee, A., Sevgen, S. E., Sanpitakseree, C., Lee, J., Schroeder, C. M., & Kenis, P. J. A. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.04.046 · Cited by 139 · see citing works
Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations
Ezadi, F., Ardebili, A., & Mirnejad, R. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01390-18 · Cited by 141 · see citing works
Polymyxin B versus colistin: an update
Cai, Y., Lee, W., & Kwa, A. L. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1093933 · Cited by 138 · see citing works
Polymyxin Resistance in Gram-negative Pathogens
Srinivas, P., & Rivard, K. R. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0596-3 · Cited by 135 · see citing works
Confronting multidrug-resistant Acinetobacter baumannii: a review
Neonakis, I., Spandidos, D. A., & Petinaki, E. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.014 · Cited by 120 · see citing works
Rodríguez, C. H., Bombicino, K. A., Granados, G., Nastro, M., Carlos, V., & Angela, F. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.05.019 · Cited by 116 · see citing works
Shi, M. Q., Kretlow, J. D., Nguyen, A., Young, S. W., Baggett, L. S., Wong, M. E., Kasper, F. K., & Mikos, A. G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.112 · Cited by 114 · see citing works
Susceptibility Testing of the Polymyxins: Where Are We Now?
Humphries, R. M. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1505 · Cited by 97 · see citing works
Cluster-dependent colistin hetero-resistance inEnterobacter cloacaecomplex
Guérin, F., Isnard, C., Sinel, C., Morand, P., Dhalluin, A., Cattoir, V., & Giárd, J.-C. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw260 · Cited by 96 · see citing works
Sherry, N. L., & Howden, B. P. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1453807 · Cited by 94 · see citing works
Jayol, A., Nordmann, P., Lehours, P., Poirel, L., & Dubois, V. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.002 · Cited by 90 · see citing works
A review on the current situation and challenges of colistin resistance in poultry production
Apostolakos, I., & Piccirillo, A. (2018) · Avian Pathology · doi:10.1080/03079457.2018.1524573 · Cited by 89 · see citing works
Landman, D., Salamera, J., & Quale, J. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02129-13 · Cited by 89 · see citing works
Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin
Turlej-Rogacka, A., Xavier, B. B., Janssens, L., Lammens, C., Zarkotou, O., Pournaras, S., Goossens, H., & Malhotra‐Kumar, S. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3140-3 · Cited by 88 · see citing works
Liang, C.-A., Lin, Y.-C., Lu, P., Chen, H.-C., Chang, H.-M., & Sheu, C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.10.033 · Cited by 87 · see citing works
Napier, B. A., Band, V. I., Burd, E. M., & Weiss, D. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02432-14 · Cited by 86 · see citing works
Major Variation in MICs of Tigecycline in Gram-Negative Bacilli as a Function of Testing Method
Marchaim, D., Pogue, J. M., Tzuman, O., Hayakawa, K., Lephart, P., Salimnia, H., Painter, T., Zervos, M., Johnson, L. E., Perri, M. B., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00001-14 · Cited by 85 · see citing works
Akers, K. S., Chaney, C., Barsoumian, A. E., Beckius, M. L., Zera, W. C., Yu, X., Guymon, C. H., Keen, E. F., ROBINSON, B. J., Mende, K., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02006-09 · Cited by 84 · see citing works
Maâlej, S., Méziou, M., Rhimi, F., & Hammami, A. (2011) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2011.03145.x · Cited by 80 · see citing works
Antimicrobial Susceptibility Testing: A Primer for Clinicians
Kuper, K. M., Boles, D. M., Mohr, J., & Wanger, A. R. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.11.1326 · Cited by 77 · see citing works
Nicoloff, H., Hjort, K., Andersson, D. I., & Wang, H. H. (2024) · Nature Communications · doi:10.1038/s41467-024-48233-0 · Cited by 70 · see citing works
Liao, W., Cui, Y., Quan, J., Zhao, D., Han, X., Shi, Q., Wang, Q. Q., Jiang, Y., Du, X., Li, X., et al. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106573 · Cited by 69 · see citing works
Lee, S. Y., Shin, J. H., Lee, K., Joo, M. Y., Park, K. H., Shin, M., Suh, S., Ryang, D. W., & Kim, S. H. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00427-13 · Cited by 69 · see citing works
Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
Vasoo, S. S. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00888-17 · Cited by 69 · see citing works
Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives
Falagas, M. E., & Rafailidis, P. I. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.973 · Cited by 67 · see citing works
Polymyxins: A Review of the Current Status Including Recent Developments
Kwa, A. L., Tam, V. H., & Falagas, M. E. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n10p870 · Cited by 66 · see citing works
Multidrug-resistant Gram-negative infections: the use of colistin
Michalopoulos, A. S., & Karatza, D. C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.88 · Cited by 64 · see citing works
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays
Kavanagh, A. M., Ramu, S., Gong, Y., Cooper, M. A., & Blaskovich, M. A. T. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01760-18 · Cited by 62 · see citing works
Boyen, F., Vangroenweghe, F. A. C. J., Butaye, P., Graef, E. D., Castryck, F., Heylen, P., Vanrobaeys, M., & Haesebrouck, F. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.01.010 · Cited by 61 · see citing works
Vourli, S., Dafopoulou, K., Vrioni, G., Tsakris, A., & Pournaras, S. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx186 · Cited by 61 · see citing works
Prim, N., Turbau, M., Rivera, A., Rodríguez-Navarro, J., Coll, P., & Mirelis, B. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.09.008 · Cited by 60 · see citing works
Resolving colistin resistance and heteroresistance in Enterobacter species
Doijad, S. P., Gisch, N., Frantz, R., Kumbhar, B. V., Falgenhauer, J. C., Imirzalioglu, C., Falgenhauer, L., Mischnik, A., Rupp, J., Behnke, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35717-0 · Cited by 59 · see citing works
Wang, X., Kang, Y., Luo, C., Zhao, T., Liu, L., Jiang, X., Fu, R., An, S., Chen, J., Jiang, N., et al. (2014) · mBio · doi:10.1128/mbio.00942-13 · Cited by 60 · see citing works
Katip, W., Rayanakorn, A., Oberdorfer, P., Taruangsri, P., & Nampuan, T. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.05.024 · Cited by 58 · see citing works
Yin, D., Guo, Y. P., Li, M., Wu, W., Tang, J., Liu, Y., Chen, F., Ni, Y., Sun, J., Zhang, H., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04123-z · Cited by 56 · see citing works
Polymyxin susceptibility testing, interpretative breakpoints and resistance mechanisms: An update
Bakthavatchalam, Y. D., Pragasam, A. K., Biswas, I., & Veeraraghavan, B. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.09.011 · Cited by 54 · see citing works
Oostdijk, E. A. N., Smits, L. P., de Smet, A. M. G. A., Hall, M. A. L., Kesecioğlu, J., & Bonten, M. J. M. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2761-3 · Cited by 53 · see citing works
Johura, F., Tasnim, J., Barman, I., Biswas, S. R., Jubyda, F. T., Sultana, M., George, C. M., Camilli, A., Seed, K. D., Ahmed, N., et al. (2020) · Gut Pathogens · doi:10.1186/s13099-020-0345-2 · Cited by 52 · see citing works
Polymyxins: Antimicrobial susceptibility concerns and therapeutic options
Veeraraghavan, B., Jeremiah, S. S., & Baliga, P. (2011) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.83905 · Cited by 51 · see citing works
Singhal, L., Sharma, M., Verma, S., Kaur, R., Britto, X. B., Kumar, S. M., Ray, P., & Gautam, V. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0251 · Cited by 48 · see citing works
Piewngam, P., & Kiratisin, P. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.06.014 · Cited by 47 · see citing works
Development of New Tools to Detect Colistin-Resistance among Enterobacteriaceae Strains
Bardet, L., & Rolain, J. (2018) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2018/3095249 · Cited by 47 · see citing works
Sun, J., Huang, S., Yang, S., Pu, S., Zhang, C.-M., & Zhang, L. P. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.12.013 · Cited by 45 · see citing works
History, Chemistry and Antibacterial Spectrum
Velkov, T., Thompson, P. E., Azad, M. A. K., Roberts, K. D., & Bergen, P. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16373-0_3 · Cited by 43 · see citing works
A simple phenotypic method for screening of MCR-1-mediated colistin resistance
Coppi, M., Cannatelli, A., Antonelli, A., Baccani, I., Pilato, V. D., Sennati, S., Giani, T., & Rossolini, G. M. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.011 · Cited by 42 · see citing works
Rapid Detection of Polymyxin-Resistant Enterobacteriaceae from Blood Cultures
Jayol, A., Dubois, V., Poirel, L., & Nordmann, P. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00918-16 · Cited by 41 · see citing works
Cherkaoui, A., Diene, S. M., Renzoni, A., Emonet, S., Renzi, G., François, P., & Schrenzel, J. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.10.009 · Cited by 41 · see citing works
Van, T. D., Dinh, Q.-D., Vu, P. D., Trung, N. V., Pham, C. V., Dao, T. T., Phung, C. D., Hoang, H. T. T., Tang, N. T., Do, N. T. T., et al. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.05.003 · Cited by 40 · see citing works
Jiménez-Pearson, M. A., Galas, M., Corso, A. C., Hormazábal, J. C., Valderrama, C. D., Marcano, N. S., Ramón-Pardo, P., & Melano, R. G. (2019) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2019.65 · Cited by 42 · see citing works
Deciphering Heteroresistance to Colistin in a Klebsiella pneumoniae Isolate from Marseille, France
Bardet, L., Baron, S. A., Leangapichart, T., Okdah, L., Diene, S. M., & Rolain, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00356-17 · Cited by 40 · see citing works
Quale, J. M., Shah, N., Kelly, P., Babu, E., Bäcker, M., Rosas-Garcia, G., Salamera, J., George, A., Bratu, S., & Landman, D. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0163 · Cited by 39 · see citing works
Lai, C., Chen, Y.-S., Lee, N., Tang, H.-J., Lee, S. S., Lin, C.-F., Lu, P., Wu, J.-J., Ko, W., Lee, W., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s194482 · Cited by 38 · see citing works
Chen, L., Lin, J., Lu, H., Zhang, X., Wang, C., Liu, H., Zhang, X., Li, J., Cao, J., & Zhou, T. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0289-2 · Cited by 38 · see citing works
Srinivas, P., Hunt, L., Pouch, S. M., Thomas, K., Goff, D. A., Pancholi, P., Balada-Llasat, J.-M., & Bauer, K. A. A. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.01.028 · Cited by 37 · see citing works
Yero, D., Huedo, P., Conchillo‐Solé, O., Martínez-Servat, S., Mamat, U., Coves, X., Alegre, F. L., Roca, I., Vilà, J., Schaible, U. E., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01160 · Cited by 38 · see citing works
Evaluation of Vitek®2 performance for colistin susceptibility testing for Gram-negative isolates
Khurana, S., Malhotra, R., & Mathur, P. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa101 · Cited by 35 · see citing works
Webb, H. E., Angulo, F. J., Granier, S. A., Scott, H. M., & Loneragan, G. H. (2017) · F1000Research · doi:10.12688/f1000research.12777.1 · Cited by 34 · see citing works
Colistin resistant Escherichia coli carrying mcr-1 in urban sludge samples: Dhaka, Bangladesh
Islam, A., Rahman, Z., Monira, S., Rahman, M. A., Camilli, A., George, C. M., Ahmed, N., & Alam, M. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0227-4 · Cited by 34 · see citing works
Cain, A. K., Boinett, C. J., Barquist, L., Dordel, J., Fookes, M. C., Mayho, M., Ellington, M. J., Goulding, D., Pickard, D., Wick, R. R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28199-y · Cited by 33 · see citing works
Zwe, Y. H., Chin, S. F., Kohli, G. S., Aung, K. T., Yang, L., & Yuk, H. (2020) · Food Microbiology · doi:10.1016/j.fm.2020.103530 · Cited by 33 · see citing works
Panigrahi, K., Pathi, B. K., Poddar, N., Sabat, S., Pradhan, S. K., Pattnaik, D., Patro, S., & Praharaj, A. K. (2022) · Cureus · doi:10.7759/cureus.28317 · Cited by 33 · see citing works
Epidemiological study of Enterobacteriaceae resistance to colistin in Sfax (Tunisia)
Maalej, S. M., Méziou, M., Mahjoubi, F., & Hammami, A. (2012) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2012.04.008 · Cited by 32 · see citing works
Sınırtaş, M., Akalın, H., & Gedikoğlu, S. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.12.012 · Cited by 31 · see citing works
Rechenchoski, D. Z., Dambrozio, A. M. L., Vivan, A. C. P., Schüroff, P. A., Burgos, T. D. N., Pelisson, M., Perugini, M. R. E., & Vespero, E. C. (2017) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2017.01.008 · Cited by 30 · see citing works
Katip, W., Yoodee, J., Uitrakul, S., & Oberdorfer, P. (2021) · Scientific Reports · doi:10.1038/s41598-020-78098-4 · Cited by 30 · see citing works
Jean, S., Liao, C., Sheng, W., Lee, W., & Hsueh, P. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2015.08.024 · Cited by 29 · see citing works
Colistin in burn intensive care: Back to the future?
Azzopardi, E., Boyce, D. E., Thomas, D. W., & Dickson, W. A. (2012) · Burns · doi:10.1016/j.burns.2012.07.015 · Cited by 27 · see citing works
Bakthavatchalam, Y. D. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/27182.10375 · Cited by 27 · see citing works
Sree, R. A., Gupta, A., Gupta, N. R., Veturi, S., Reddy, L. S. K., Begum, M., Etrouth, S., Challa, H. R., Reddy, S. S., Singamsetty, A., et al. (2023) · Infection · doi:10.1007/s15010-023-02094-9 · Cited by 26 · see citing works
Pasterán, F. G., Danze, D., Menocal, A., Cabrera, C., Castillo, I., Albornoz, E., Lucero, C., Rapoport, M., Ceriana, P., & Corso, A. C. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01701-20 · Cited by 26 · see citing works
Lopes, S. P., Jorge, P., Sousa, A. M., & Pereira, M. O. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1863329 · Cited by 26 · see citing works
Polymyxin Susceptibility Testing: a Cold Case Reopened
Jerke, K. H., Lee, M. J., & Humphries, R. M. (2016) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2016.04.003 · Cited by 24 · see citing works
Uechi, K., Tada, T., Shimada, K., Nakasone, I., Kirikae, T., & Fujita, J. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.09.004 · Cited by 24 · see citing works
Tzeng, Y., Berman, Z., Toh, E. C., Bazan, J. A., Turner, A. N., Retchless, A. C., Wang, X., Nelson, D. E., & Stephens, D. S. (2018) · Molecular Microbiology · doi:10.1111/mmi.14153 · Cited by 23 · see citing works
Főldes, A., Székely, E., Voidăzan, S. T., & Dobreanu, M. (2022) · Antibiotics · doi:10.3390/antibiotics11030377 · Cited by 24 · see citing works
Perez, L. R. R. (2015) · Apmis · doi:10.1111/apm.12438 · Cited by 22 · see citing works
- Authors
- Lo-Ten-Foe, J. R., de Smet, A. M. G. A., Diederen, B. M. W., Kluytmans, J. A. J. W., & van Keulen, P. H. J.
- Affiliations
- Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands
- Perioperative and Emergency Care, Utrecht Medical Center, Utrecht, The Netherlands
- Amphia Ziekenhuis (NL)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-10
- Volume
- 51
- Issue
- 10
- Pages
- 3726-3730
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2043258
- OpenAlex
- W2142419984
- Cited by
- 242
- References
- 22
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 16 · 2023: 19 · 2022: 14 · 2021: 9 · 2020: 22 · 2019: 16 · 2018: 19 · 2017: 24 · 2016: 13 · 2015: 11 · 2014: 9 · 2013: 11 · 2012: 7
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Pharmacology › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- colistin, colistin susceptibility testing, heteroresistance, Enterobacter cloacae, Acinetobacter baumannii, disk diffusion, E-test, broth microdilution, agar dilution, VITEK 2, selective decontamination of the digestive tract, intensive care unit, Gram-negative bacteria, antibiotic resistance
- MeSH terms
- Acinetobacter Infections, Agar, Anti-Bacterial Agents, Bacterial Infections, Colistin, Cross Infection, Culture Media, Enterobacteriaceae Infections, Humans, Intensive Care Units, Microbial Sensitivity Tests, Polymyxin B, Enterobacter cloacae, Drug Resistance, Multiple, Bacterial, Acinetobacter baumannii
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review